Repurposing pentoxifylline for the treatment of fibrosis: an overview
Fibrosis is a potentially debilitating disease with high morbidity rates. It is estimated that half of all deaths that occur in the USA are attributed to fibrotic disorders. Fibrotic disorders are characterized primarily by disruption in the extracellular matrix deposition and breakdown equilibrium,...
Үндсэн зохиолчид: | Wen, W, Lee, S, Siang, R, Koh, R |
---|---|
Формат: | Journal article |
Хэл сонгох: | English |
Хэвлэсэн: |
Springer Nature
2017
|
Ижил төстэй зүйлс
Ижил төстэй зүйлс
-
Pentoxifylline in patients with oral submucous fibrosis
-н: Ashwini Deshpande, зэрэг
Хэвлэсэн: (2015-01-01) -
Efficacy of pentoxifylline in the management of oral submucous fibrosis
-н: Santosh Patil, зэрэг
Хэвлэсэн: (2014-01-01) -
Pentoxifylline Inhibits Pulmonary Fibrosis by Regulating Cellular Senescence in Mice
-н: Yifan Lin, зэрэг
Хэвлэсэн: (2022-05-01) -
Pentoxifylline in the Treatment of Acute Alcoholic Hepatitis
-н: Arun S, зэрэг
Хэвлэсэн: (2014-07-01) -
Pentoxifylline: An Immunomodulatory Drug for the Treatment of COVID-19
-н: Hiren A. Dhameliya, зэрэг
Хэвлэсэн: (2020-05-01)